4.6 Review

Revisiting the regulatory roles of the TGF-β family of cytokines

Journal

AUTOIMMUNITY REVIEWS
Volume 15, Issue 9, Pages 917-922

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.autrev.2016.07.007

Keywords

B cell; Regulatory T cell; TGF-beta; Integrin

Categories

Funding

  1. AbbVie
  2. Astellas
  3. BMS
  4. Daiichi-Sankyo
  5. MitsubishiTanabe
  6. Pfizer
  7. Sanofi
  8. Santen
  9. Takeda
  10. Teijin
  11. Boehringer Ingelheim
  12. Chugai
  13. Eisai
  14. Ono
  15. Taisho Toyama
  16. UCB
  17. ImmunoFuture
  18. Asahi Kasei
  19. Janssen

Ask authors/readers for more resources

TGF-beta family members are multipotent cytokines that are involved in many cellular processes, including cell differentiation, organ development, wound healing and immune regulation. TGF-beta has pleiotropic effects on adaptive immunity, especially in the regulation of CD4(+) T cell and B cell responses. Furthermore, identification of CD4(+) T cell subsets that produce TGF-beta 3 revealed unexpected roles of TGF-beta 3 in the control of adaptive immunity. In contrast to TGF-beta 1, which induces extensive fibrosis, TGF-beta 3 induces non-scarring wound healing and counteracts tissue fibrosis. Recent progress in the understanding of the activation mechanism of TGF-beta may enable us to develop novel biologic therapies based on advanced protein engineering. (C) 2016 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available